Skip to main content

Find Clinical Trials

Home
Conditions
Complement Component 3 Deficiency, Autosomal Recessive

Clinical trial condition

Complement Component 3 Deficiency, Autosomal Recessive

Explore clinical trials studying Complement Component 3 Deficiency, Autosomal Recessive. Study availability and eligibility vary by location and protocol.

3 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Complement Component 3 Deficiency, Autosomal Recessive trial results

Recruiting

A Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G

NCT06419205

Conditions: Autoimmune Diseases, C3 (Complement Component 3) Glomerulopathy, Complement Component 3 Deficiency, Autosomal Recessive, +16 more
Locations: Investigator Site #1 Lawrenceville, Georgia, United States

Investigator Site #2 São Paulo, Brazil

View Trial Details

Enrolling by invitation

Immune System in Diabetic Kidney Disease

NCT07292493

Conditions: Complement Component 3 Deficiency, Autosomal Recessive, Complement System, Diabetes, +14 more
Locations: University Medical Centre Ljubljana Ljubljana, Slovenia

View Trial Details

Completed

The De-novo Use of Eculizumab in Presensitized Patients Receiving Cardiac Transplantation

NCT02013037

Conditions: Antibody-mediated Rejection, Cardiac Allograft Vasculopathy, Cardiovascular Diseases, +7 more
Locations: Cedars Sinai Medical Center, Heart Institute Los Angeles, California, United States

View Trial Details